Claude LeClerc,Pierre Guermonprez,Daniel Ladant,Nicole Guiso,Nadia Khelef,Cecile Bauche,Catherine Fayolle,Mohammed El-Azami El-Idrissi
申请号：
US15177029
公开号：
US10004794B2
申请日:
2016.06.08
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The invention relates to a novel use of a Bordetella adenylcyclase toxin in the manufacturing of vectors for targeting in vivo a molecule of interest, specifically to CD11b expressing cells. The invention also relates to an immunogenic composition that primes immune responses, to pharmaceutical compositions and to a new vector for molecule delivery to CD11b expressing cells.
